National Resilience

San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
mRNA Gene Therapy Cell Therapy Lentiviral
9 confirmed programs · 8 sponsors · Last scored 2026-04-29
74.5
Signal Score
✓ FDA Inspections (1) ✓ Clinical Trials (9) ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: National Resilience

Signal Score
74.5/100 (as of 2026-04-29)
Quality Compliance
98.0/100
Headquarters
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Modalities
mRNA, Gene Therapy, Cell Therapy, Lentiviral
Active Programs
9 confirmed from ClinicalTrials.gov across 8 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About National Resilience

$800M+ raised.

Signal Score & Pillar Breakdown

Quality Compliance 98.0
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-21)
Operations 58.3
9 active programs across 8 sponsors
Modalities: Cell Therapy, Lentiviral, mRNA, Gene Therapy
3 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
9 active programs across 8 sponsors · Modalities: Cell Therapy, Lentiviral, mRNA, Gene Therapy · 3 programs in advanced phases (Phase 2/3)
Programs 9
Sponsors8
ModalitiesmRNA, Gene Therapy, Cell Therapy, Lentiviral
9 active programs across 8 sponsors
Modalities: Cell Therapy, Lentiviral, mRNA, Gene Therapy
3 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT07190755 Impact of Patient-Reported Outcomes for Symptom Monitoring in... NA Recruiting
NCT06364631 CARE1 Pragmatic Clinical Trial PHASE3 Recruiting
NCT06072612 Study of the Bria-IMT Regimen and CPI vs Physicians' Choice... PHASE3 Recruiting
NCT05835895 Safety and Pharmacodynamics of GNSC-001 Intra-articular... PHASE1 Active Not Recruiting
NCT05298293 Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma NA Not Yet Recruiting
NCT04023071 FT516 in Subjects With Advanced Hematologic Malignancies PHASE1 Terminated
NCT04093622 Long-term Follow-Up Study Following Treatment With Fate... NA Terminated
NCT00073463 Safety and Efficacy of Recombinant Adeno-Associated Virus... PHASE2/PHASE3 Terminated
NCT03601442 CTL019 Out of Specification MAP for ALL or DLBCL Patients NA Available
Source: ClinicalTrials.gov · Retrieved Aug 22, 2026
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 68.0
3 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Research Triangle Park, NC, Boston, MA, San Diego, CA
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
StatusAvailable
3 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Research Triangle Park, NC, Boston, MA, San Diego, CA
3 manufacturing sites
Broad modality coverage (4 modalities)

National Resilience FDA Inspection History

2025-01
NAI VAI OAI
Date Site Type Observations Classification
2025-01-21 West Chester, Ohio Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Aug 22, 2026

Frequently Asked Questions About National Resilience

How many FDA inspections does National Resilience have on record?
CDMO Signal tracks 1 FDA inspection for National Resilience, sourced from the FDA inspection database. See the full inspection history above.
Has National Resilience received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for National Resilience.
How many clinical programs is National Resilience linked to?
National Resilience is associated with 9 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is National Resilience's CDMO Signal Score?
National Resilience has a Signal Score of 74/100, based on quality, operations, financial stability, and capacity data.
Evaluating National Resilience for a manufacturing program?
Use the free AI matchmaker to compare National Resilience against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs → Gene Therapy CDMOs → Cell Therapy CDMOs → Lentiviral CDMOs →

Similar CDMOs

Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, Monoclonal Antibody, Recombinant Protein
Landmark Bio
Watertown, MA
AAV, Lentiviral, CAR-T, Cell Therapy, mRNA, LNP, Extracellular Vesicles, Gene Editing
Lonza
Basel, Switzerland
Signal Score: 78.2
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA